In addition, the company’s product pipeline also includes, OPT-88, a therapy for osteoarthritis; OPT-822, a carbohydrate-based cancer immunotherapy to treat metastatic breast cancer; OP-1068/CEM-101, macrolide and ketolide antibiotics to treat respiratory …
